PPBT logo

Purple Biotech Ltd.

PPBT
Healthcare|Biotechnology|IL
$1.31
+0.06 (+4.80%)
DCF Value
$1.39
Tangible Book / Share
$0.45
Cash / Share
$0.56

Ownership Breakdown

94.5%
Float
0.1M
Shares Outstanding
0.1M
Float Shares

Major Holders (9)

Combined: 64.9%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Intracoastal Capital LLCOther9.99%282,513,535May 13, 202613D/G
Mitchell P. KopinHC, IN9.99%282,513,535May 13, 202613D/G
Daniel B. AsherHC, IN9.99%282,513,535May 13, 202613D/G
Lincoln Alternative Strategies LLCOther9.90%605,000Sep 9, 202513D/G
Armistice Capital, LLCIA, OO8.69%223,000Nov 14, 202413D/G
Steven BoydHC, IN8.69%223,000Nov 14, 202413D/G
Orca Capital AGCorporation4.90%306,394Sep 9, 202513D/G
G1 Execution Services, LLCBD, OO1.40%26,532,000Aug 14, 202613D/G
Susquehanna Securities, LLCBD, OO1.40%26,532,000Aug 14, 202613D/G

Insider Trades (14)

Last 4 quarters: 0 acquired · 0 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Rock SimchadirectorMar 18, 2026OTHER0——Form 4
Rock SimchadirectorMar 18, 2026OTHER2,650,000——Form 4
Zilberberg SuzanadirectorMar 18, 2026OTHER0——Form 4
Zilberberg SuzanadirectorMar 18, 2026OTHER2,650,000——Form 4
Agmon IdodirectorMar 18, 2026OTHER0——Form 4
Agmon IdodirectorMar 18, 2026OTHER2,650,000——Form 4
Efron GilChief Executive OfficerMar 18, 2026OTHER0——Form 4
Efron GilChief Executive OfficerMar 18, 2026OTHER13,500,000——Form 4
Schickler MichaelHead of Clinical & Reg AffairsMar 18, 2026OTHER0——Form 4
Schickler MichaelHead of Clinical & Reg AffairsMar 18, 2026OTHER7,100,000——Form 4
Lankry Shai SdirectorMar 18, 2026OTHER0——Form 4
Lankry Shai SdirectorMar 18, 2026OTHER3,550,000——Form 4
Gagnon Robert E.directorMar 18, 2026OTHER0——Form 4
Gagnon Robert E.directorMar 18, 2026OTHER2,650,000——Form 4